Grastek — Medica
grass pollen-induced allergic rhinitis
Initial criteria
- age ≥ 5 years
- Therapy timing meets ONE of the following (i or ii): i) Grastek therapy initiated 12 weeks prior to the expected onset of the grass pollen season OR dosed daily continuously for consecutive grass pollen seasons; OR ii) Oralair therapy initiated 4 months prior to the expected onset of the grass pollen season
- Diagnosis confirmed by ONE of the following (i or ii): i) positive skin test response to a grass pollen from the Pooideae subfamily of grasses (e.g., sweet vernal, Kentucky blue grass, Timothy grass, orchard, or perennial rye grass); OR ii) positive in vitro test for allergen-specific immunoglobulin E antibodies for a grass in the Pooideae subfamily of grasses
Approval duration
1 year